Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
30/06/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
28/06/2023 | 1001(L) | +6,631,000(L) | HKD3.519(L) | 192,746,000(L) | 5.12 | |
28/06/2023 | UBS Group AG | 1013(L) 1402(S) | +300,554,500(L) +218,500,000(S) | 477,797,810(L) 365,647,890(S) | 12.70 9.72 | |
03/05/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Life Sciences Group Ltd | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Nelumbo Investments Limited | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Shorea LBG | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Liu Dianbo | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Liu Dianbo | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Pharma Holdings Ltd. | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Ginkgo (PTC) Limited | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Life Sciences Group Ltd | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | LuYe Pharmaceutical International Co., Ltd. | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Ginkgo (PTC) Limited | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Nelumbo Investments Limited | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Pharma Holdings Ltd. | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Shorea LBG | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
22/02/2023 | Liu Dianbo | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | Hillhouse Investment Management, Ltd. | 1213(L) | 552,324,108(L) | 14.68 | ||
22/02/2023 | Hillhouse Fund V, L.P. | 1213(L) | 552,324,108(L) | 14.68 | ||
22/02/2023 | Shorea LBG | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | Nelumbo Investments Limited | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | Ginkgo (PTC) Limited | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | Luye Pharma Holdings Ltd. | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | LuYe Pharmaceutical International Co., Ltd. | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | Hillhouse NEV Holdings Limited | 1213(L) | 552,324,108(L) | 14.68 | ||
22/02/2023 | Luye Life Sciences Group Ltd | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
20/01/2023 | Leung Man Kit | 12041(L) | -250,000(L) | 0(L) 0(S) | 0.00 0.00 | |
20/01/2023 | Zhang Huaqiao | 12041(L) | -250,000(L) | 0(L) 0(S) | 0.00 0.00 | |
20/01/2023 | Lo Yuk Lam | 12041(L) | -250,000(L) | 0(L) 0(S) | 0.00 0.00 | |
20/01/2023 | Song Rui Lin | 12041(L) | -250,000(L) | 0(L) 0(S) | 0.00 0.00 | |
20/01/2023 | CHOY Sze Chung Jojo | 12041(L) | -250,000(L) | 0(L) 0(S) | 0.00 0.00 | |
1 2 3 4 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
Real time quote last updated: 23/08/2024 18:00 | |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |